List of Excipients in API PROCHLORPERAZINE EDISYLATE
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing PROCHLORPERAZINE EDISYLATE
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Hikma Pharmaceuticals USA Inc | prochlorperazine edisylate | 0641-6135 | BENZYL ALCOHOL |
Hikma Pharmaceuticals USA Inc | prochlorperazine edisylate | 0641-6135 | SACCHARIN SODIUM |
Hikma Pharmaceuticals USA Inc | prochlorperazine edisylate | 0641-6135 | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for PROCHLORPERAZINE EDISYLATE
Excipient focus: BENZYL ALCOHOL
PROCHLORPERAZINE EDISYLATE drug variants containing BENZYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | prochlorperazine edisylate | 0641-6135 |
Cosette Pharmaceuticals Inc | prochlorperazine edisylate | 0713-0351 |
Nexus Pharmaceuticals Inc | prochlorperazine edisylate | 14789-700 |
>Company | >Ingredient | >NDC |
PROCHLORPERAZINE EDISYLATE drug variants not containing BENZYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | prochlorperazine edisylate | 0641-6225 |
>Company | >Ingredient | >NDC |
Excipient focus: SACCHARIN SODIUM
PROCHLORPERAZINE EDISYLATE drug variants containing SACCHARIN SODIUM
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | prochlorperazine edisylate | 0641-6135 |
Hikma Pharmaceuticals USA Inc | prochlorperazine edisylate | 0641-6225 |
Cosette Pharmaceuticals Inc | prochlorperazine edisylate | 0713-0351 |
>Company | >Ingredient | >NDC |
PROCHLORPERAZINE EDISYLATE drug variants not containing SACCHARIN SODIUM
Company | Ingredient | NDC |
---|---|---|
Physicians Total Care Inc | prochlorperazine edisylate | 54868-0261 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, MONOBASIC
PROCHLORPERAZINE EDISYLATE drug variants containing SODIUM PHOSPHATE, MONOBASIC
PROCHLORPERAZINE EDISYLATE drug variants not containing SODIUM PHOSPHATE, MONOBASIC
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | prochlorperazine edisylate | 0641-6135 |
Hikma Pharmaceuticals USA Inc | prochlorperazine edisylate | 0641-6225 |
Cosette Pharmaceuticals Inc | prochlorperazine edisylate | 0713-0351 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, MONOBASIC ANHYDROUS
PROCHLORPERAZINE EDISYLATE drug variants containing SODIUM PHOSPHATE, MONOBASIC ANHYDROUS
Company | Ingredient | NDC |
---|---|---|
Physicians Total Care Inc | prochlorperazine edisylate | 54868-0261 |
>Company | >Ingredient | >NDC |
PROCHLORPERAZINE EDISYLATE drug variants not containing SODIUM PHOSPHATE, MONOBASIC ANHYDROUS
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | prochlorperazine edisylate | 0641-6135 |
Hikma Pharmaceuticals USA Inc | prochlorperazine edisylate | 0641-6225 |
Cosette Pharmaceuticals Inc | prochlorperazine edisylate | 0713-0351 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
PROCHLORPERAZINE EDISYLATE drug variants containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | prochlorperazine edisylate | 0641-6135 |
Hikma Pharmaceuticals USA Inc | prochlorperazine edisylate | 0641-6225 |
Cosette Pharmaceuticals Inc | prochlorperazine edisylate | 0713-0351 |
>Company | >Ingredient | >NDC |
PROCHLORPERAZINE EDISYLATE drug variants not containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
Excipient focus: SODIUM TARTRATE
PROCHLORPERAZINE EDISYLATE drug variants containing SODIUM TARTRATE
PROCHLORPERAZINE EDISYLATE drug variants not containing SODIUM TARTRATE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | prochlorperazine edisylate | 0641-6135 |
Hikma Pharmaceuticals USA Inc | prochlorperazine edisylate | 0641-6225 |
Cosette Pharmaceuticals Inc | prochlorperazine edisylate | 0713-0351 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM TARTRATE DIHYDRATE
PROCHLORPERAZINE EDISYLATE drug variants containing SODIUM TARTRATE DIHYDRATE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | prochlorperazine edisylate | 0641-6135 |
Hikma Pharmaceuticals USA Inc | prochlorperazine edisylate | 0641-6225 |
Cosette Pharmaceuticals Inc | prochlorperazine edisylate | 0713-0351 |
>Company | >Ingredient | >NDC |
PROCHLORPERAZINE EDISYLATE drug variants not containing SODIUM TARTRATE DIHYDRATE
Excipient focus: WATER
PROCHLORPERAZINE EDISYLATE drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | prochlorperazine edisylate | 0641-6135 |
Hikma Pharmaceuticals USA Inc | prochlorperazine edisylate | 0641-6225 |
Cosette Pharmaceuticals Inc | prochlorperazine edisylate | 0713-0351 |
>Company | >Ingredient | >NDC |
PROCHLORPERAZINE EDISYLATE drug variants not containing WATER
Company | Ingredient | NDC |
---|---|---|
Physicians Total Care Inc | prochlorperazine edisylate | 54868-0261 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.